Anagram Therapeutics's $250M: A Big Biotech Bet Amid AI's Spotlight
Anagram Therapeutics raised $250M in May 2026, one of the largest biotech rounds of the period, proving life-sciences capital is alive alongside AI.
healthtech - VC Tracker Resources
Discover comprehensive resources and guides related to healthtech. Our comprehensive guides cover VC analysis preparation, investment resources, and practical advice for investors and analysts.
Whether you're an investor preparing for market analysis, a portfolio manager helping with investment tracking, or an analyst looking for resources, you'll find valuable insights in the articles below.
Related Articles (18 articles)
NYC Digital Health Raised $2.4B in H1 2025: The Sector Data Every Founder Should Know
NYC digital health raised $2.4B in H1 2025 (+10% YoY). Life sciences took 27% of NYC venture funding. Here's where the money went and who's writing checks.
Parallel's €17M Series A: Paris Healthtech Doubles Down on Coding Agents
Parallel's Paris round highlights Europe's growing confidence in vertical AI agents for regulated industries like healthcare.
July 2025 Life Sciences Mega Close: Frazier Life Sciences Closes $1.3B Fund XII
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
July 2025 VC Fund Close: Modi Ventures Closes $88M Fund II for Tech-Bio Convergence
Houston-based Modi Ventures closed its oversubscribed second fund at $88 million on July 16, 2025, investing at the intersection of AI, biology, and medical technology.
NYC Health API Funding: Junction Raises $18M to Connect Wearables and Labs
Junction, now headquartered in New York, announced an $18M funding round on March 11, 2025, to scale infrastructure linking wearable data and lab workflows.